Valuation Caplin Point Laboratories Limited NSE India S.E.

Stocks

Market Closed - NSE India S.E. Other stock markets 12:05:07 02/07/2026 BST			5-day change	1st Jan Change
2,538.20 ^INR	-1.01%		+0.76%	+38.09%

05-15	Caplin Point Laboratories Limited, Q4 2026 Earnings Call, May 14, 2026
05-14	Caplin Point Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	30,571	51,529	45,291	100,038	152,221	193,617	-	-
Change	-	68.55%	-12.11%	120.88%	52.16%	27.19%	-	-
Enterprise Value (EV)	30,571	51,529	45,291	100,038	152,221	193,617	193,617	193,617
Change	-	68.55%	-12.11%	120.88%	52.16%	27.19%	0%	0%
P/E	12.7x	17.3x	12.1x	22x	28.5x	17.9x	27.2x	23.8x
PBR	2.58x	3.47x	2.41x	4.32x	5.34x	3.19x	4.4x	4x
PEG	-	0.7x	0.5x	1x	1.6x	0.9x	1.7x	1.7x
Capitalization / Revenue	2.88x	4.06x	3.09x	5.91x	7.86x	5.23x	7.78x	6.9x
EV / Revenue	0x	0x	0x	0x	0x	9.1x	7.78x	6.9x
EV / EBITDA	0x	0x	0x	0x	0x	26.1x	22.5x	19.7x
EV / EBIT	0x	0x	0x	-	0x	24.9x	20.8x	18x
EV / FCF	0x	0x	0x	0x	0x	51x	35.2x	35.8x
FCF Yield	6.39%	4.77%	1.72%	1.73%	1.58%	2.4%	2.84%	2.8%
Dividend per Share ²	3	2	2	2.5	3	-	4	4
Rate of return	0.74%	0.29%	0.34%	0.19%	0.15%	-	0.16%	0.16%
EPS ²	31.71	39.26	49.18	59.9	70.25	84.11	93.8	107
Distribution rate	9.46%	5.09%	4.07%	4.17%	4.27%	-	4.26%	3.74%
Net sales ¹	10,613	12,694	14,667	16,941	19,375	21,872	24,880	28,053
EBITDA ¹	3,286	3,947	4,411	5,514	6,469	7,609	8,604	9,810
EBIT ¹	3,152	3,478	4,520	-	5,810	8,036	9,321	10,752
Net income ¹	2,423	2,998	3,763	4,571	5,363	6,412	7,128	8,124
Net Debt	-	-	-	-	-	-	-	-
Reference price ²	404.15	679.90	596.70	1,317.30	2,002.60	2,547.20	2,547.20	2,547.20
Nbr of stocks (in thousands)	75,643	75,789	75,903	75,942	76,012	76,012	-	-
Announcement Date	06/05/21	12/05/22	27/05/23	16/05/24	15/05/25	14/05/26	-	-

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
SUN PHARMACEUTICAL INDUSTRIES LTD.	38.49x	7.3x	24.89x	0.81%	47.1B
OTSUKA HOLDINGS CO., LTD.	17.73x	1.99x	9.41x	1.36%	34.57B
CIPLA LIMITED	28.05x	3.47x	17.77x	0.86%	12.38B
ZYDUS LIFESCIENCES LIMITED	24.33x	4.21x	15.68x	0.73%	11.64B
KRKA, D. D.	19.29x	3.32x	12.08x	3.54%	8.87B
GEDEON RICHTER	8.47x	1.99x	5.22x	5.12%	7.1B
ONO PHARMACEUTICAL CO., LTD.	15.95x	2.02x	6.81x	3.31%	6.85B
GLENMARK PHARMACEUTICALS LIMITED	32.82x	3.73x	15.86x	0.24%	6.42B
Average	23.14x	3.50x	13.47x	2%	16.87B
Weighted average by Cap.	26.74x	4.34x	16.25x	1.45%